Spinal astrocyte gap junction and glutamate transporter expression contributes to a rat model of bortezomib-induced peripheral neuropathy

Neuroscience

Volumn 285, Issue , 2015, Pages 1-10

  Robinson, C R ^a,b   Dougherty, P M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

Bortezomib; Connexin 43; GFAP; GLAST; GLT 1; Minocycline

Indexed keywords

BORTEZOMIB; CALCIUM; CARBENOXOLONE; CEFTRIAXONE; CONNEXIN 43; EXCITATORY AMINO ACID TRANSPORTER; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE TRANSPORTER; MINOCYCLINE; OXALIPLATIN; PACLITAXEL; TOLL LIKE RECEPTOR 4; CENTRAL NERVOUS SYSTEM AGENTS; CONNEXIN 43 PROTEIN, RAT; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; SLC1A2 PROTEIN, RAT; SLC1A3 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BEHAVIOR CHANGE; BORTEZOMIB INDUCED PERIPHERAL NEUROPATHY; CELL MEMBRANE; CHRONIC PAIN; CONTROLLED STUDY; GAP JUNCTION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PERIPHERAL NEUROPATHY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; HYPERALGESIA; METABOLISM; PAIN THRESHOLD; PATHOLOGY; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYSIOLOGY; SPINAL CORD; SPRAGUE DAWLEY RAT;

ANIMALS; ASTROCYTES; BORTEZOMIB; CARBENOXOLONE; CEFTRIAXONE; CENTRAL NERVOUS SYSTEM AGENTS; CONNEXIN 43; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GAP JUNCTIONS; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPERALGESIA; MALE; MINOCYCLINE; PAIN THRESHOLD; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 84913601296     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.11.009     Document Type: Article

References (32)

1. Aguirre A., Maturana C.J., Harcha P.A., Sáez J.C. Possible involvement of TLRs and hemichannels in stress-induced CNS dysfunction via mastocytes, and glia activation. Mediators Inflamm 2013, 2013:893521.
2. Argyriou A.A., Bruna J., Marmiroli P., Cavaletti G. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol 2012, 82:51-77.
3. Argyriou A.A., Kyritsis A.P., Makatsoris T., Kalofonos H.P. Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature. Cancer Manage Res 2014, 6:135-147.
4. Boyette-Davis J., Dougherty P.M. Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline. Exp Neurol 2011, 229:353-357.
5. Boyette-Davis J., Xin W., Zhang H., Dougherty P.M. Intraepidermal nerve fiber loss corresponds to the development of Taxol-induced hyperalgesia and can be prevented by treatment with minocycline. Pain 2011, 152:308-313.
6. Cata J.P., Weng H.R., Chen J.H., Dougherty P.M. Altered discharges of spinal wide dynamic range neurons and down-regulation of glutamate transporter expression in rats with paclitaxel-induced hyperalgesia. Neuroscience 2006, 138:329-338.
7. Chen G., Park C.K., Xie R.G., Berta T., Nedergaard M., Ji R.R. Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain following spinal cord injury. Brain 2014, 137:2193-2209.
8. Chen M.J., Kress B., Han X., Moll K., Peng W., Ji R.R., Nedergaard M. Astrocytic CX43 hemichannels and gap junctions play a crucial role in development of chronic neuropathic pain following spinal cord injury. Glia 2012, 60:1660-1670.
9. Devinsky O., Vessani A., Najjar S., de Lanerolle N.C., Rogawski M.A. Glia and epilepsy: excitability and inflammation. Trends Neurosci 2013, 36:174-184.
10. Ferrier J., Pereira V., Busserolles J., Authier N., Balayssac D. Emerging trends in understanding chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep 2013, 17:364.
11. Giaume C., Liu X. From a glial syncytium to a more restricted and specific glial networking. J Physiol Paris 2012, 106:34-39.
12. Hansen R.R., Malcangio M. Astrocytes - multitaskers in chronic pain. Eur J Pharmacol 2013, 716:120-128.
13. Homkajorn B., Sims N.R., Muyderman H. Connexin 43 regulates astrocytic migration and proliferation in response to injury. Neurosci Lett 2010, 486:197-201.
14. Juszczak G.R., Swiergiel A.H. Properties of gap junction blockers and their behavioral, cognitive and electrophysiological effects: animal and human studies. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:181-198.
15. Kim K., Lee S.G., Kegelman T.P., Su Z.Z., Das S.K., Dash R., Dasgupta S., Barral P.M., Hedvat M., Diaz P., Reed J.C., Stebbins J.L. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol 2011, 226:2484-2493.
16. Lee S.G., Su Z.Z., Embad L., Gupta P., Sarkar D., Borjabad A., Volsky D.J., Fisher P.B. Mechanisms of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J Biol Chem 2008, 283:13116-13123.
17. Li Y., Zhang H., Zhang H., Kosturakis A.K., Jawad A.B., Dougherty P.M. Toll-like receptor 4 signaling in primary sensory neurons and spinal astrocytes contribute to paclitaxel-induced peripheral neuropathy. J Pain 2014, 15:712-725.
18. López-Bayghen E., Ortega A. Glial glutamate transporters: new actors in brain signaling. IUBMB Life 2011, 63:816-823.
19. Malarkey E.B., Parpura V. Mechanisms of glutamate release from astrocytes. Neurochem Int 2008, 52:142-154.
20. Matute C., Domercq M., Sanchez-Gomez M.V. Glutamate-mediated glial injury: mechanisms and clinical importance. Glia 2006, 53:212-224.
21. Miltenburg N.C., Boogerd W. Chemotherapy-induced neuropathy: a comprehensive survey. Cancer Treat Rev 2014, 40:872-882.
22. Nakagawa T., Kaneko S. Spinal astrocytes as therapeutic targets for pathological pain. J Pharmacol Sci 2010, 114:347-353.
23. Pannasch U., Rouach N. Emerging role for astroglial networks in information processing: from synapse to behavior. Trends Neurosci 2013, 36:405-417.
24. Robinson C.R., Zhang H., Dougherty P.M. Altered discharges of spinal wide dynamic range neurons parallel the behavioral phenotype shown by rats with bortezomib related chemotherapy induced peripheral neuropathy. Brain Res 2014, 1574:6-13.
25. Robinson C.R., Zhang H., Dougherty P.M. Astrocytes, but not microglia, are activated in oxaliplatin and bortezomib-induced peripheral neuropathy. Neuroscience 2014, 274:308-317.
26. Solan J.L., Lampe P.D. Key connexin43 phosphorylation events regulate the gap junction life cycle. J Membr Biol 2007, 217:35-41.
27. Tabernero A., Medina J.M., Giaume C. Glucose metabolism and proliferation in glia: role of astrocytic gap junctions. J Neurochem 2006, 99:1049-1061.
28. Theis M., Giaume C. Connexin-based intercellular communication and astrocyte heterogeneity. Brain Res 2012, 1487:88-98.
29. Weng H.-R., Cordella J.V., Dougherty P.M. Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia. Pain 2003, 103:131-138.
30. Yi J.H., Hazell A.S. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury. Neurochem Int 2006, 48:394-403.
31. Yoon S.-Y., Robinson C.R., Zhang H., Dougherty P.M. Gap junction protein connexin 43 is involved in the induction of oxaliplatin-related neuropathic pain. J Pain 2013, 14:205-214.
32. Zhang H., Yoon S.-Y., Zhang H., Dougherty P.M. Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of paclitaxel-induced painful neuropathy. J Pain 2012, 13:293-303.